Majd Atalla
Lawyers
Filters
Roche Holdings $2.5 billion notes offering
We advised Roche on the offering comprising three tranches of notes
Aker BP cash tender offers
The offers were for notes due 2025 and 2026
Oesterreichische Kontrollbank $1 billion notes offering
The 3.75% notes are due 2029
Clariane €92 million reserved capital increase and €237 million rights offering
We advised Clariane on its refinancing transactions
Roche Holdings $3.875 billion notes offering
We advised Roche on the Rule 144A / Regulation S offering comprising four tranches of notes
SEB $1.75 billion notes offering
The investment-grade notes are due 2027 and 2029
Forbion European Acquisition $138 million combination with enGene
We advised Forbion European Acquisition on its de-SPAC transaction
Diageo Capital $1.7 billion notes offering
The investment-grade notes are due 2026 and 2033
Aker BP $1.5 billion notes offering
The notes are due 2028 and 2033
Bed Bath & Beyond chapter 11 filing
We are advising the ABL agent in connection with the restructuring